Zivo Bioscience, Inc. Warrants
ZIVOW
ZIVOW was delisted on the 24th of November, 2023.
4 hedge funds and large institutions have $68K invested in Zivo Bioscience, Inc. Warrants in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
42% less capital invested
Capital invested by funds: $118K → $68K (-$50K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCA
Verdence Capital Advisors
Hunt Valley,
Maryland
|
+$11.4K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$11.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$350 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$36.4K |
ZIVOW Hedge Fund Activity: Q3 2021 in Review
4 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q3 2021, worth a combined $68K — down 42% from $118K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ZIVOW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Verdence Capital Advisors, opening a new position worth an estimated $11.4K. The largest seller was CVI Holdings, cutting an estimated $36.4K.
- 4 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q3 2021, up from 3 in Q2 2021.
- Funds reported $68K of Zivo Bioscience, Inc. Warrants stock for Q3 2021, down 42% quarter-over-quarter.
- 1 fund opened new Zivo Bioscience, Inc. Warrants positions in Q3 2021 and 0 closed out, a net change of +1 holder.
- The largest Zivo Bioscience, Inc. Warrants buyer in Q3 2021 was Verdence Capital Advisors, an estimated $11.4K added.
- The largest Zivo Bioscience, Inc. Warrants seller in Q3 2021 was CVI Holdings, an estimated $36.4K sold.
Based on aggregated 13F filings for Q3 2021.